Efstathia Karagkiozi
Overview
Explore the profile of Efstathia Karagkiozi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cancelloni V, Buratti M, Tsivgoulis G, Furie K, Tadi P, Caso V, et al.
Neurol Sci
. 2024 May;
45(10):4895-4902.
PMID: 38775860
Background: Intravenous thrombolysis (IVT) and/or endovascular therapy (EVT) are currently considered best practices in acute stroke patients. Data regarding the efficacy and safety of reperfusion therapies in patients with atrial...
2.
Siskou O, Galanis P, Konstantakopoulou O, Stafylas P, Karagkouni I, Tsampalas E, et al.
Healthcare (Basel)
. 2023 Sep;
11(18).
PMID: 37761742
The aim of this study was to measure the one-year total cost of strokes and to investigate the value of stroke care, defined as cost per QALY. The study population...
3.
Paciaroni M, Caso V, Romoli M, Becattini C, Salerno A, Rapillo C, et al.
Eur Stroke J
. 2023 Jul;
8(4):1030-1040.
PMID: 37452632
Introduction: The best therapeutic strategy for patients with mechanical heart valves (MHVs) having acute ischemic stroke during treatment with vitamin K antagonists (VKAs) remain unclear. Being so, we compared the...
4.
Siskou O, Galanis P, Konstantakopoulou O, Karagkouni I, Tsampalas E, Garefou D, et al.
Stud Health Technol Inform
. 2022 Jan;
289:439-442.
PMID: 35062185
Methods: Direct medical costs (diagnostic imaging and clinical laboratory exams, overheads/bed cost, pharmaceuticals, ringers and other non-durables and inpatient rehabilitation) per patient were calculated from the providers' (hospitals') perspective. Resource...
5.
Galanis P, Konstantakopoulou O, Karagkouni I, Gallos P, Tsampalas E, Lypiridou M, et al.
Stud Health Technol Inform
. 2022 Jan;
289:392-396.
PMID: 35062174
Methods: Stroke patient-reported experiences (n=387) were recorded using the translated and culturally adapted NHS-Stroke Questionnaire into Greek and staff experiences (n=236) were investigated using the Compassion Satisfaction and Burnout subscales...
6.
Mavraganis G, Korompoki E, Tsampalas E, Garefou D, Alexopoulou H, Lypiridou M, et al.
Stud Health Technol Inform
. 2022 Jan;
289:325-328.
PMID: 35062158
Methods: The study population derived from the web-based SUN4P registry included 823 patients with first-ever acute stroke. Descriptive statistics were used to present patients' characteristics. Results: The vast majority of...
7.
Tiili P, Leventis I, Kinnunen J, Svedjeback I, Lehto M, Karagkiozi E, et al.
Ann Med
. 2021 Sep;
53(1):1613-1620.
PMID: 34498537
Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable efficacy profile compared to vitamin-K antagonists (VKAs), with more convenient dosing schemes. However, issues with adherence to the...
8.
Ntaios G, Sagris D, Kallipolitis A, Karagkiozi E, Korompoki E, Manios E, et al.
J Stroke Cerebrovasc Dis
. 2021 Aug;
30(10):106018.
PMID: 34343838
Materials And Methods: Two prospective stroke registries with consecutive acute ischemic stroke patients were used as training/validation and test datasets. The outcome assessed was major adverse cardiovascular event, defined as...
9.
Paciaroni M, Agnelli G, Giustozzi M, Tsivgoulis G, Yaghi S, Mac Grory B, et al.
Eur Stroke J
. 2021 Feb;
5(4):374-383.
PMID: 33598556
Introduction: The aim of this study in patients with acute posterior ischaemic stroke (PS) and atrial fibrillation (AF) was to evaluate (1) the risks of recurrent ischaemic event and severe...
10.
Giustozzi M, Acciarresi M, Agnelli G, Caso V, Bandini F, Tsivgoulis G, et al.
Stroke
. 2020 Jul;
51(8):2347-2354.
PMID: 32646335
Background And Purpose: The optimal timing for starting oral anticoagulant after an ischemic stroke related to atrial fibrillation remains a challenge, mainly in patients treated with systemic thrombolysis or mechanical...